Magalasin, Rolando B.
HRN: 24-66-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/07/2024
03/14/2024
IV
600mg
Every 6 Hours
Carbuncle Upper Back Secondary To Uncontrolled DM
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes